Arthur Gelb is a Respiratory physician affiliated with University of California, Los Angeles. OpenAlex indexes 144 publications with 5,544 citations (h-index 40); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3650 South St
Suite 308
Lakewood, CA 907121502
Telephone
562-633-2275Registry record last updated 8 Jul 2007.
Clinical trials
- Detection of Unsuspected Small Airways Obstruction in Cystic Fibrosis
Sponsor: Gelb, Arthur F., M.D.
- Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap
Sponsor: Gelb, Arthur F., M.D.
- Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Sponsor: Gelb, Arthur F., M.D.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
33 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year202531 payments
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20259 payments
- Insmed, Inc.Program year202518 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Long-term safety and efficacy of twice-daily aclidinium bromide in patients with COPD
Respiratory Medicine
2013 - Unsuspected mild emphysema in nonsmoking patients with chronic asthma with persistent airway obstruction
Journal of Allergy and Clinical Immunology
2013 - Efficacy and Safety of a 12-week Treatment with Twice-daily Aclidinium Bromide in COPD Patients (ACCORD COPD I)
COPD Journal of Chronic Obstructive Pulmonary Disease
2012
Similar KOLs
Other experts from the same institution or the same specialty.
Dennis Slamon, MD
University of California, Los Angeles
Beth Karlan, MD
University of California, Los Angeles
Richard Casaburi, MD
University of California, Los Angeles
Jerome Engel, MD
University of California, Los Angeles
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”